drug

rocuronium

1 story · latest Oct 9, 2026

Follow rocuronium. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 2025 · NDA217472, NDA219108
Trials: 1 registered trial in coverage

Relationships

Developed by Fresenius Kabi

Also known as

rocuronium bromide

Timeline

Merck registers Phase 2b trial of tulisokibart for noninfectious uveitis

Oct 9Weekly roundup, 8 itemsglycopyrrolate Merck & Co., Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.